Table 2.
Factors associated with renal impairment (eGFR <60 mL/min/1.73m2), n = 193.
Univariate |
Adjusted for age and sex |
Adjusted for HIV factors |
Adjusted for renal factors |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PR | 95% CI | p value | PR | 95% CI | p value | PR | 95% CI | p value | PR | 95% CI | p value | |||
African Region of Ancestry | <0.001 | <0.001 | <0.001 | <0.001 | ||||||||||
East | 1 | 1 | 1 | 1 | ||||||||||
South | 0.89 | 0.58–1.37 | 0.59 | 0.94 | 0.61–1.44 | 0.76 | 0.87 | 0.54–1.41 | 0.58 | 0.90 | 0.56–1.44 | 0.67 | ||
Central | 1.09 | 0.57–2.11 | 0.79 | 1.10 | 0.58–2.10 | 0.76 | 0.85 | 0.40–1.82 | 0.68 | 0.69 | 0.29–1.68 | 0.41 | ||
West | 1.92 | 1.33–2.78 | 0.001 | 2.04 | 1.12–2.93 | <0.001 | 2.00 | 1.35–2.96 | 0.001 | 2.06 | 1.40–3.04 | <0.001 | ||
Age (per 1 year increment) | 1.05 | 1.04–1.07 | <0.001 | 1.05 | 1.04–1.07 | <0.001 | 1.05 | 1.03–1.06 | <0.001 | 1.04 | 1.02–1.06 | <0.001 | ||
Sex (Female vs. male) | 0.62 | 0.47–0.81 | <0.001 | 0.77 | 0.53–1.01 | 0.06 | 0.97 | 0.71–1.31 | 0.83 | 0.97 | 0.72–1.32 | 0.87 | ||
Time since HIV diagnosis (5 years increments) | 1.05 | 0.95–1.17 | 0.31 | |||||||||||
Nadir CD4 (50 cell/mm3 increment) | 0.88 | 0.8/3–0.93 | <0.001 | 0.94 | 0.89–0.99 | 0.03 | 0.95 | 0.90–1.00 | 0.05 | |||||
Current CD4 (50 cell/mm3 increment) | 0.93 | 0.90–0.97 | <0.001 | 0.96 | 0.92–1.00 | 0.06 | 0.95 | 0.92–0.99 | 0.007 | |||||
On ART | 0.62 | 0.21–1.81 | 0.38 | |||||||||||
HIV viral load (<200 copies/mL) | 1.09 | 0.62–1.91 | 0.77 | |||||||||||
Mode of HIV Acquisition | 0.26 | |||||||||||||
Heterosexual | 1 | |||||||||||||
MSM | 1.61 | 0.64–4.07 | 0.32 | |||||||||||
Vertical | 0.48 | 0.19–1.27 | 0.14 | |||||||||||
Blood products | 1.93 | 0.67–5.54 | 0.22 | |||||||||||
Unknown | 1.21 | 0.73–2.01 | 0.45 | |||||||||||
Prior AIDS | 1.76 | 1.33–2.32 | <0.001 | 1.66 | 1.19–2.29 | 0.003 | 1.52 | 1.09–2.11 | 0.01 | |||||
HBsAg (positive) | 0.96 | 0.53–1.73 | 0.89 | |||||||||||
Anti-HCV (Positive) | 3.63 | 1.97–6.69 | <0.001 | 3.48 | 1.84–6.57 | <0.001 | 2.97 | 1.44–6.14 | 0.003 | |||||
Diabetes | 3.20 | 2.38–4.30 | <0.001 | 2.15 | 1.52–3.03 | <0.001 | ||||||||
Hypertension | 16.24 | 10.40–25.35 | <0.001 | |||||||||||
Cardiovascular disease | 3.83 | 2.71–5.40 | <0.001 | 2.94 | 1.98–4.35 | <0.001 | ||||||||
BMI (kg/m2) | ||||||||||||||
<18.5 | 1.64 | 0.44–6.12 | 0.46 | |||||||||||
18.5–24.99 | 1 | |||||||||||||
25–30 | 0.82 | 0.56–1.91 | 0.30 | |||||||||||
>=30 | 0.84 | 0.59–1.20 | 0.34 |
ART=antiretroviral therapy; MSM=men who have sex with men; AIDS=acquired immunodeficiency syndrome; HBsAg=hepatitis B surface antigen; Anti-HCV=hepatitis C virus antibody; BMI=body mass index; PR=prevalence ratio; CI=confidence interval.